Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
CEN Case Reports|September 30, 2024
Effective calcineurin inhibitor treatment in adult-onset steroid-resistant nephrotic syndrome with a novel splice donor site variant of TRPC6: a case reportTomoki Nagasaka, Kiyotaka Uchiyama, Eriko Yoshida Hama, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 11, 2024
Subsequent high blood pressure and hypertension by hypertensive disorders of pregnancy: the Tohoku Medical Megabank Project Birth and Three-Generation Cohort StudyMami Ishikuro, Taku Obara, Mayu Hasegawa, et al.
Aging Cell|September 29, 2025
Vascular Endothelial NAMPT-Mediated NAD+ Biosynthesis Regulates Angiogenesis and Cardiometabolic Functions in Male MiceShotaro Kosugi, Shintaro Yamaguchi, Ken Nishioka, et al.
Scientific Reports|April 17, 2022
The significance of NAD + metabolites and nicotinamide N-methyltransferase in chronic kidney diseaseRina Takahashi, Takeshi Kanda, Motoaki Komatsu, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 23, 2023
Clinical significance of serum urea-to-creatinine ratio in patients undergoing peritoneal dialysisShun Tonomura, Kiyotaka Uchiyama, Takashin Nakayama, et al.
Scientific Reports|July 3, 2026
A hypofunctional PREX1 variant (p.Y191C) leads to neurodevelopmental abnormalities and epilepsy by attenuating RAC1 signalingMasashi Nishikawa, Yuri Uchiyama, Kazuyuki Nakamura, et al.
Aging Cell|April 22, 2026
The Mitochondrial NAD Transporter SLC25A51 in Adipocytes Regulates Adipose Tissue Mitochondrial Function and Systemic Metabolism During AgingDaiki Kojima, Keisuke Yaku, Shotaro Kosugi, et al.
CEN Case Reports|April 16, 2025
Taurine supplementation improves physical activity level in a hemodialysis patient with mitochondrial disease: a case reportRyuto Yoshida, Ryunosuke Mitsuno, Takashin Nakayama, et al.
Kidney International Reports|July 18, 2025
Erratum to "Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan" [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1063-1075]Kiyotaka Uchiyama, Daisuke Kamano, Tomoki Nagasaka, et al.
Kidney International Reports|April 30, 2025
Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving TolvaptanKiyotaka Uchiyama, Daisuke Kamano, Tomoki Nagasaka, et al.
Pageof 12